A sustained-release dyphylline nasal spray and preparation method thereof
Through the sustained-release dihydroxypropylene nasal spray, the use of MOF and corn starch latex to control drug release, the slow onset and side effects of existing dosing methods are solved, and the effect of quickly alleviating asthma symptoms and improving compliance is achieved. .
Patent Information
- Application Number
- CN202410568106.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-09
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-05-09
AI Technical Summary
The existing dihydroxypropylene administration methods have problems such as slow onset, low bioavailability, short duration, frequent administration and high risk of side effects, and no nasal spray preparation methods have been reported.
Using sustained-release dihydroxypropyl theylline nasal spray, the drug release rate is controlled through MOF and corn starch latex as carriers, and it is delivered directly to the nasal cavity and bronchial to reduce systemic adverse reactions. The preparation method includes the preparation of MOF and corn starch latex and Spray drying process of drugs.
It has achieved rapid relief of asthma symptoms, improved local efficacy, extended drug efficacy, reduced the number of dosing and systemic side effects, improved patient compliance, and simple preparation process for large-scale production.
Abstract
Description
Technical Field
[0001] The invention relates to the field of pharmaceutical preparations, and in particular to a sustained-release dyphylline nasal spray and a preparation method thereof. Background Art
[0002] Asthma is a common respiratory disease and a frequently-occurring disease. There are more than 100 million asthma patients in the world. The prevalence of asthma in my country is close to 1%, with more than 10 million patients, half of whom develop the disease before the age of 12. Asthma is a disease that seriously harms people's physical and mental health, reduces their ability to work, and reduces their quality of life. It is also difficult to cure. It manifests as sudden chest tightness, irritating cough, and respiratory difficulties with wheezing, mainly on exhalation. The attack time can be long or short, and in severe cases it can last for several weeks, or it can be a chronic course of repeated attacks, so the treatment of asthma is urgent.
[0003] Dyphylline is a bronchodilator used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease. It is a derivative of theophylline and has similar pharmacological effects to theophylline, but has a longer duration of action. Currently, the administration of dyphylline includes tablets and injections. Tablets are convenient to take, but they are slow to take effect, have low bioavailability, and a short duration. Frequent administration is required and may cause gastrointestinal irritation. Although the injection takes effect quickly, patient compliance is poor, the risk of side effects is high, and professional injection is required. At present, there is no report on the preparation of dyphylline as a nasal spray.
[0004] Preparing dyphylline into a nasal spray is convenient for use and improves patient compliance. However, issues that need to be considered are that dyphylline may be unstable in the nasal spray, inappropriate dosage may irritate the nasal mucosa, and the absorption capacity is limited. Summary of the invention
[0005] In view of this, the present invention provides a sustained-release dyphylline nasal spray and a preparation method thereof. By controlling the drug release rate, the drug is directly delivered to the nasal cavity and bronchus, which is rapidly absorbed, has little irritation, and reduces systemic adverse reactions.
[0006] The technical solution of the present invention is achieved in this way:
[0007] A sustained-release dyphylline nasal spray is prepared from the following raw materials in parts by weight: 0.5-2.5 parts of dyphylline, 10-20 parts of MOF, 10-15 parts of corn starch latex, and 0.1-0.5 parts of sodium citrate.
[0008] Furthermore, the preparation method of the MOF includes: adding trimethylsulfonic acid and aluminum nitrate to a 60%-80% v / v ethanol solution, adding triethylamine and stirring, centrifuging, washing and drying to obtain Al-MOF, adding Al-MOF and 3-aminopropyltriethoxysilane to water, ultrasonically treating, filtering, washing and drying to obtain the target MOF.
[0009] The present invention selects Al-MOF to load drugs, which will not cause irritation and damage to the nasal mucosa, has high stability, and is suitable for nasal administration. The silane coupling agent 3-aminopropyltriethoxysilane is added to modify the Al-MOF, which can enhance the subsequent affinity with corn starch latex and improve the subsequent dispersibility in corn starch latex.
[0010] Furthermore, the molar ratio of trimethylsulfonic acid to aluminum nitrate is 1-2:1; the volume ratio of trimethylsulfonic acid to ethanol solution is 1:1-2; the molar ratio of triethylamine to aluminum nitrate is 2-3:1; the stirring time is 12-24h; the mass ratio of Al-MOF to 3-aminopropyltriethoxysilane is 1:0.5-1; the amount of water added is 5-10 times the total mass of Al-MOF and 3-aminopropyltriethoxysilane; and the ultrasonic treatment time is 1-3h.
[0011] Furthermore, the preparation method of the corn starch latex comprises: dispersing corn starch in water, ultrasonic treatment, continuously adding water for boiling, and cooling to room temperature to obtain the latex.
[0012] Furthermore, the weight ratio of corn starch to water is 2-4:1; the speed of the ultrasonic wave is 500-600 rpm, the time is 10-20 min, and the temperature is 40-60° C.; and the amount of water added continuously is 50%-70% of the weight of the corn starch.
[0013] A method for preparing a sustained-release dyphylline nasal spray, the specific steps comprising:
[0014] (1) adding MOF to corn starch latex, ultrasonically treating the latex to obtain a mixture, and placing the mixture in an electrospinning device to obtain MOF / corn starch nanofibers;
[0015] (2) dispersing dyphylline in water, stirring, adding MOF / corn starch nanofibers, adding sodium citrate to adjust the pH to 6.0-7.0, homogenizing, spray drying, and obtaining a mixture powder;
[0016] (3) dispersing the mixed powder in water, stirring and packaging to obtain the target sustained-release dyphylline nasal spray.
[0017] Furthermore, in step (1), the concentration of the corn starch latex is 10%-15% w / v; the ultrasonic treatment time is 20-30 min, and the rotation speed is 800-1000 rpm; the voltage of the electrospinning device is 10-20 kV, and the time is 15-25 min.
[0018] The invention further limits the concentration of corn starch latex, thereby ensuring that the final nasal spray does not form gel and increasing the retention time of the nasal spray.
[0019] Furthermore, in step (2), the solid-liquid ratio of the diphylline to water is 1:10-20 g / mL; the stirring time is 20-30 min; the homogenization time is 5-10 min, the power is 200-300 W, and the temperature is 30-40° C.; and the spray drying temperature is 80-100° C.
[0020] Furthermore, in step (3), the solid-liquid ratio of the mixture powder to water is 1:30-40 g / mL; and the stirring time is 15-25 min.
[0021] A sustained-release dyphylline nasal spray is prepared by any of the above-mentioned preparation methods.
[0022] Compared with the prior art, the present invention has the following beneficial effects:
[0023] 1. The prepared sustained-release dyphylline nasal spray of the present invention provides sustained release and can also quickly relieve symptoms. The dyphylline nasal spray of the present invention is administered through the nasal cavity, directly acts on the respiratory tract, takes effect quickly, exerts a bronchial dilation effect, and improves local efficacy. The sustained-release effect is good, adheres to the nasal mucosa, prolongs the efficacy, has little irritation, reduces systemic side effects, reduces the number of administrations, and is convenient for patients to use, improves patient compliance, and the preparation process of the dyphylline nasal spray of the present invention is simple, easy to scale production, and has good application prospects.
[0024] 2. The corn starch latex of the present invention is used as a carrier, has good biocompatibility, uniform distribution, improves the deposition efficiency of drugs in the nasal cavity, prolongs the retention time, can control the drug release rate, has a simple preparation process and low cost. MOF is a porous material with strong targeting, which can achieve targeted drug delivery to specific parts of the nasal cavity. The pore structure of MOF can regulate the release rate of drugs and achieve a sustained release effect. Combining corn starch latex and MOF, synergistically enhancing, and achieving more precise drug release control can enhance the therapeutic effect, enhance stability, and reduce systemic side effects. DETAILED DESCRIPTION
[0025] In order to better understand the technical content of the present invention, specific embodiments are provided below to further illustrate the present invention.
[0026] Unless otherwise specified, the experimental methods used in the embodiments of the present invention are all conventional methods.
[0027] Unless otherwise specified, the materials, reagents, etc. used in the embodiments of the present invention can be obtained from commercial sources.
[0028] Example 1
[0029] A sustained-release dyphylline nasal spray is prepared from the following raw materials in parts by weight: 1.5 parts of dyphylline, 15 parts of MOF, 13 parts of corn starch latex, and 0.3 parts of sodium citrate.
[0030] The preparation method of the above-mentioned sustained-release dyphylline nasal spray specifically comprises the following steps:
[0031] (1) adding trimethylsulfonic acid and aluminum nitrate in a molar ratio of 1.5:1 to a 70% v / v ethanol solution, wherein the volume ratio of trimethylsulfonic acid to the ethanol solution is 1:1.5, adding triethylamine and stirring for 18 h, wherein the molar ratio of triethylamine to aluminum nitrate is 2.5:1, centrifuging, washing with water and ethanol twice in sequence, and drying to obtain Al-MOF, adding Al-MOF and 3-aminopropyltriethoxysilane in a mass ratio of 1:0.8 to water, wherein the amount of water added is 8 times the total mass of Al-MOF and 3-aminopropyltriethoxysilane, ultrasonically treating at 250 rpm and 25°C for 2 h, filtering, washing with water and ethanol twice in sequence, and drying to obtain the target MOF;
[0032] (2) dispersing corn starch in water, with a weight ratio of corn starch to water of 3:1, ultrasonically treating for 15 min at a speed of 550 rpm and a temperature of 50° C., continuously adding water in an amount of 60% of the weight of the corn starch, boiling, and cooling to room temperature to obtain corn starch latex;
[0033] (3) adding MOF to corn starch latex with a concentration of 13% w / v, stirring for 25 min under ultrasound at a speed of 900 rpm to obtain a mixture, placing the mixture in an electrospinning device for 20 min, the solvent is dimethylformamide, and the voltage is 15 kV to obtain MOF / corn starch nanofibers;
[0034] (4) dispersing diphylline in water with a solid-liquid ratio of diphylline to water of 1:15 g / mL, stirring for 25 min, adding MOF / corn starch nanofibers, adding sodium citrate to adjust the pH to 6.5±0.1, homogenizing at a power of 250 W and a temperature of 35° C. for 8 min, and spray drying at a temperature of 90° C. to obtain a mixture powder;
[0035] (5) The mixed powder was dispersed in water with a solid-liquid ratio of the mixed powder to water being 1:35 g / mL, stirred for 20 min, and packaged to obtain the target sustained-release diphylline nasal spray.
[0036] Example 2
[0037] A sustained-release dyphylline nasal spray is prepared from the following raw materials in parts by weight: 0.5 parts of dyphylline, 10 parts of MOF, 10 parts of corn starch latex, and 0.1 parts of sodium citrate.
[0038] The preparation method of the above-mentioned sustained-release dyphylline nasal spray specifically comprises the following steps:
[0039] (1) adding trimethylsulfonic acid and aluminum nitrate in a molar ratio of 1:1 to a 60% v / v ethanol solution, wherein the volume ratio of trimethylsulfonic acid to the ethanol solution is 1:1, adding triethylamine and stirring for 12 h, wherein the molar ratio of triethylamine to aluminum nitrate is 2:1, centrifuging, washing with water and ethanol twice in sequence, and drying to obtain Al-MOF, adding Al-MOF and 3-aminopropyltriethoxysilane in a mass ratio of 1:0.5 to water, wherein the amount of water added is 5 times the total mass of Al-MOF and 3-aminopropyltriethoxysilane, ultrasonically treating at 200 rpm and 20°C for 1 h, filtering, washing with water and ethanol twice in sequence, and drying to obtain the target MOF;
[0040] (2) dispersing corn starch in water, with the weight ratio of corn starch to water being 2:1, ultrasonically treating for 10 min at a speed of 500 rpm and a temperature of 40° C., continuously adding water in an amount of 50% of the weight of the corn starch, boiling, and cooling to room temperature to obtain corn starch latex;
[0041] (3) adding MOF to corn starch latex with a concentration of 10% w / v, stirring for 20 min under ultrasound at a speed of 800 rpm to obtain a mixture, placing the mixture in an electrospinning device for 15 min, the solvent is dimethylformamide, and the voltage is 10 kV to obtain MOF / corn starch nanofibers;
[0042] (4) dispersing diphylline in water with a solid-liquid ratio of diphylline to water of 1:10 g / mL, stirring for 20 min, adding MOF / corn starch nanofibers, adding sodium citrate to adjust the pH to 6.1±0.1, homogenizing at a power of 200 W and a temperature of 30° C. for 5 min, and spray drying at a temperature of 80° C. to obtain a mixture powder;
[0043] (5) The mixed powder was dispersed in water with a solid-liquid ratio of the mixed powder to water being 1:30 g / mL, stirred for 15 min, and packaged to obtain the target sustained-release diphylline nasal spray.
[0044] Example 3
[0045] A sustained-release dyphylline nasal spray is prepared from the following raw materials in parts by weight: 2.5 parts of dyphylline, 20 parts of MOF, 15 parts of corn starch latex, and 0.5 parts of sodium citrate.
[0046] The preparation method of the above-mentioned sustained-release dyphylline nasal spray specifically comprises the following steps:
[0047] (1) adding trimethylsulfonic acid and aluminum nitrate in a molar ratio of 2:1 to an 80% v / v ethanol solution, wherein the volume ratio of trimethylsulfonic acid to the ethanol solution is 1:2, adding triethylamine and stirring for 24 h, wherein the molar ratio of triethylamine to aluminum nitrate is 3:1, centrifuging, washing with water and ethanol twice in sequence, and drying to obtain Al-MOF, adding Al-MOF and 3-aminopropyltriethoxysilane in a mass ratio of 1:1 to water, wherein the amount of water added is 10 times the total mass of Al-MOF and 3-aminopropyltriethoxysilane, ultrasonically treating at 300 rpm and 30°C for 3 h, filtering, washing with water and ethanol twice in sequence, and drying to obtain the target MOF;
[0048] (2) dispersing corn starch in water, with the weight ratio of corn starch to water being 4:1, ultrasonically treating for 20 min at a speed of 600 rpm and a temperature of 60° C., continuously adding water in an amount of 70% of the weight of the corn starch, boiling, and cooling to room temperature to obtain corn starch latex;
[0049] (3) adding MOF to corn starch latex with a concentration of 15% w / v, stirring for 30 min under ultrasound at a speed of 1000 rpm to obtain a mixture, placing the mixture in an electrospinning device for 25 min, the solvent is dimethylformamide, and the voltage is 20 kV to obtain MOF / corn starch nanofibers;
[0050] (4) dispersing diphylline in water at a solid-liquid ratio of diphylline to water of 1:20 g / mL, stirring for 30 min, adding MOF / corn starch nanofibers, adding sodium citrate to adjust the pH to 6.9±0.1, homogenizing at a power of 300 W and a temperature of 40° C. for 10 min, and spray drying at a temperature of 100° C. to obtain a mixture powder;
[0051] (5) The mixed powder was dispersed in water with a solid-liquid ratio of the mixed powder to water being 1:40 g / mL, stirred for 25 min, and packaged to obtain the target sustained-release diphylline nasal spray.
[0052] Comparative Example 1
[0053] The difference from Example 1 is that the amount of raw materials is different; the rest is the same as Example 1.
[0054] A sustained-release dyphylline nasal spray is prepared from the following raw materials in parts by weight: 0.4 parts of dyphylline, 8 parts of MOF, 9 parts of corn starch latex, and 0.08 parts of sodium citrate.
[0055] Comparative Example 2
[0056] The difference from Example 1 is that corn starch latex is missing; the rest is consistent with Example 1.
[0057] A sustained-release dyphylline nasal spray is prepared from the following raw materials in parts by weight: 1.5 parts of dyphylline, 15 parts of MOF, and 0.3 parts of sodium citrate.
[0058] The preparation method of the above-mentioned sustained-release dyphylline nasal spray specifically comprises the following steps:
[0059] (1) adding trimethylsulfonic acid and aluminum nitrate in a molar ratio of 1.5:1 to a 70% v / v ethanol solution, wherein the volume ratio of trimethylsulfonic acid to the ethanol solution is 1:1.5, adding triethylamine and stirring for 18 h, wherein the molar ratio of triethylamine to aluminum nitrate is 2.5:1, centrifuging, washing with water and ethanol twice in sequence, and drying to obtain Al-MOF, adding Al-MOF and 3-aminopropyltriethoxysilane in a mass ratio of 1:0.8 to water, wherein the amount of water added is 8 times the total mass of Al-MOF and 3-aminopropyltriethoxysilane, ultrasonically treating at 250 rpm and 25°C for 2 h, filtering, washing with water and ethanol twice in sequence, and drying to obtain the target MOF;
[0060] (2) placing the MOF in an electrospinning device for 20 min, using dimethylformamide as the solvent and 15 kV as the voltage to obtain MOF nanofibers;
[0061] (3) dispersing diphylline in water with a solid-liquid ratio of diphylline to water of 1:15 g / mL, stirring for 25 min, adding MOF nanofibers, adding sodium citrate to adjust the pH to 6.5±0.1, homogenizing at a power of 250 W and a temperature of 35° C. for 8 min, and spray drying at a temperature of 90° C. to obtain a mixture powder;
[0062] (4) The mixed powder was dispersed in water with a solid-liquid ratio of the mixed powder to water being 1:35 g / mL, stirred for 20 min, and packaged to obtain the target sustained-release diphylline nasal spray.
[0063] Comparative Example 3
[0064] The difference from Example 1 is that MOF is missing; the rest is the same as Example 1.
[0065] A sustained-release dyphylline nasal spray is prepared from the following raw materials in parts by weight: 1.5 parts of dyphylline, 13 parts of corn starch latex, and 0.3 parts of sodium citrate.
[0066] The preparation method of the above-mentioned sustained-release dyphylline nasal spray specifically comprises the following steps:
[0067] (1) dispersing corn starch in water, with a weight ratio of corn starch to water of 3:1, ultrasonically treating for 15 min at a speed of 550 rpm and a temperature of 50° C., continuously adding water in an amount of 60% of the weight of the corn starch, boiling, and cooling to room temperature to obtain corn starch latex;
[0068] (2) dispersing diphylline in water at a solid-liquid ratio of diphylline to water of 1:15 g / mL, stirring for 25 min, adding corn starch latex, adding sodium citrate to adjust the pH to 6.5±0.1, homogenizing at a power of 250 W and a temperature of 35° C. for 8 min, and spray drying at a temperature of 90° C. to obtain a mixture powder;
[0069] (3) The mixture powder was dispersed in water with a solid-liquid ratio of the mixture powder to water being 1:35 g / mL, stirred for 20 min, and packaged to obtain the target sustained-release diphylline nasal spray.
[0070] Test example
[0071] Experimental animals: sick chickens diagnosed with asthma bronchitis based on epidemiology, clinical symptoms, pathological autopsy, pathogen isolation and identification.
[0072] Grouping and administration method: 160 rats were randomly selected and divided into 8 groups, each with 20 rats, namely, Example 1-3 group, Comparative Example 1-3 group, blank group, and control group. Example 1-3 group and Comparative Example 1-3 group were treated with the sustained-release dihydroxypropylline nasal spray prepared in Example 1-3 and Comparative Example 1-3, respectively. The blank control group did not use any drug. The control group used commercially available dihydroxypropylline tablets (purchased from Tianjin Pacific Pharmaceutical Co., Ltd.) for 3 consecutive days. The Example 1-3 group and the Comparative Example 1-3 group were administered 0.5 mL each time through the nasal cavity, twice a day, and the dihydroxypropylline tablets of the control group were administered 0.5 g each time, twice a day.
[0073] Efficacy criteria: Cure: Symptoms such as wheezing and coughing disappear, and do not recur for about 3 days after stopping medication;
[0074] Effective: Symptoms such as asthma and coughing are significantly improved;
[0075] Ineffective: No significant improvement in symptoms.
[0076] The efficacy was observed and the number of cured, effective and ineffective patients was counted, and the total effective rate was calculated. The test results are shown in Table 1 below.
[0077] Table 1
[0078] sample Cure / only Valid / only Invalid / only Total effective rate / % Blank Group - - - - Control group 6 9 5 75% Example 1 15 5 0 100% Example 2 13 7 0 100% Example 3 14 6 0 100% Comparative Example 1 10 8 2 90% Comparative Example 2 7 9 4 80% Comparative Example 3 8 9 3 85%
[0079] As can be seen from Table 1, the total effective rate of Examples 1-3 in treating sick chickens with asthma and bronchitis is 100%, while the control group is only 75%, indicating that the sustained-release dihydroxypropyltheophylline nasal spray prepared by the present invention has good efficacy in treating asthma and bronchitis, and is superior to commercially available dihydroxypropyltheophylline tablets. The difference between Comparative Example 2 and Example 1 is that corn starch latex is lacking, resulting in a decrease in cure rate and total effective rate, indicating that corn starch latex can improve the deposition efficiency of drugs in the nasal cavity, prolong the retention time, control the drug release rate, and improve the therapeutic effect. The difference between Comparative Example 3 and Example 1 is that MOF is lacking, indicating that MOF achieves targeted drug delivery to specific parts of the nasal cavity, and the pore structure of MOF can regulate the release rate of drugs, achieve a sustained release effect, and improve the therapeutic effect. The present invention combines corn starch latex and MOF to achieve synergistic synergy, achieve more accurate drug release control, and enhance the therapeutic effect.
[0080] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A sustained-release dyphylline nasal spray, characterized in that: The product is prepared from the following raw materials in parts by weight: 0.5-2.5 parts of diphylline, 10-20 parts of MOF, 10-15 parts of corn starch latex, and 0.1-0.5 parts of sodium citrate; The preparation method of the MOF comprises: adding trimethylsulfonic acid and aluminum nitrate to a 60%-80% v / v ethanol solution, adding triethylamine and stirring, centrifuging, washing and drying to obtain Al-MOF, adding Al-MOF and 3-aminopropyltriethoxysilane to water, ultrasonically treating, filtering, washing and drying to obtain the target MOF; The method for preparing corn starch latex comprises: dispersing corn starch in water, ultrasonic treatment, adding water to boil, cooling to room temperature, and obtaining corn starch latex; The preparation method of the sustained-release dyphylline nasal spray comprises the following specific steps: (1) adding MOF to corn starch latex, ultrasonically treating the latex to obtain a mixture, and placing the mixture in an electrospinning device to obtain MOF / corn starch nanofibers; (2) dispersing dyphylline in water, stirring, adding MOF / corn starch nanofibers, adding sodium citrate to adjust the pH to 6.0-7.0, homogenizing, spray drying, and obtaining a mixture powder; (3) dispersing the mixed powder in water, stirring and packaging to obtain the target sustained-release dyphylline nasal spray.
2. A sustained-release dyphylline nasal spray according to claim 1, characterized in that: In the preparation method of MOF, the molar ratio of trimethylsulfonic acid to aluminum nitrate is 1-2:1; the volume ratio of trimethylsulfonic acid to ethanol solution is 1:1-2; the molar ratio of triethylamine to aluminum nitrate is 2-3:1; the stirring time is 12-24 hours; the mass ratio of Al-MOF to 3-aminopropyltriethoxysilane is 1:0.5-1; the amount of water added is 5-10 times the total mass of Al-MOF and 3-aminopropyltriethoxysilane; and the ultrasonic treatment time is 1-3 hours.
3. A sustained-release dyphylline nasal spray according to claim 1, characterized in that: In the preparation method of corn starch latex, the weight ratio of corn starch to water is 2-4:1; the rotation speed of the ultrasonic wave is 500-600rpm, the time is 10-20min, and the temperature is 40-60℃; the amount of water added continuously is 50%-70% of the weight of the corn starch.
4. A sustained-release dyphylline nasal spray according to claim 1, characterized in that: In step (1), the concentration of the corn starch latex is 10%-15% w / v; the ultrasonic treatment time is 20-30 minutes, the rotation speed is 800-1000 rpm; the voltage of the electrospinning device is 10-20 kV, and the time is 15-25 minutes.
5. A sustained-release dyphylline nasal spray according to claim 1, characterized in that: In step (2), the solid-liquid ratio of the diphylline to water is 1:10-20 g / mL; the stirring time is 20-30 min; the homogenization time is 5-10 min, the power is 200-300 W, and the temperature is 30-40° C.; the spray drying temperature is 80-100° C.
6. A sustained-release dyphylline nasal spray according to claim 1, characterized in that: In step (3), the solid-liquid ratio of the mixture powder to water is 1:30-40 g / mL; and the stirring time is 15-25 min.
